Clinical aspects of tuberculosis

December 2004
Thorax;Dec2004 Supplement, Vol. 59, p36
Academic Journal
The article presents some papers related to clinical aspects of tuberculosis. Rates of tuberculosis in London have almost doubled in the last decade and the disease has become concentrated in risk groups whose health and social care needs are underserved. Cross sectional survey including 2010 of 2080 (97%) patients with tuberculosis in London on 1 July 2003. Prevalence estimates are based on census and other published denominators and analyses were undertaken on factors related poor adherence, relapse, and drug resistance. Rates of tuberculosis in London are now highest in those groups who are hardest to reach and hardest to treat.


Related Articles

  • Outpatient-based DOT reduces treatment cost of MDR tuberculosis.  // PharmacoEconomics & Outcomes News;6/4/2005, Issue 479, p10 

    Discusses research being done on the outpatient-based treatment of multidrug-resistant tuberculosis in San Francisco, California. Reference to a study by M. Burgos et al, published in the April 2005 issue of "Clinical Infectious Diseases"; Effectiveness of the treatment; Importance of the...

  • Effect of drug resistance on the generation of secondary cases of tuberculosis. Burgos, Marcos; DeRiemer, Kathryn; Small, Peter M.; Hopewell, Philip C.; Daley, Charles L. // Journal of Infectious Diseases;12/15/2003, Vol. 188 Issue 12, p1878 

    Background: The results of animal studies suggest that isoniazid-resistant strains of Mycobacterium tuberculosis are less pathogenic than isoniazid-susceptible strains. Here, we assess the relative pathogenicity of drug-resistant and drug-susceptible strains, in a human...

  • Molecular analysis of drug resistant TB. Meizer, M.; Brown, T. J.; French, G. L.; Dickens, A.; McHugh, T. D.; Bagg, L. R.; Storring, R. A.; Lacey, S. // Thorax;Jun2002, Vol. 57 Issue 6, p562 

    Since the mid 1980s the number of notified cases of tuberculosis (TB) in Great Britain has continued to rise with the largest increases noted in London and inner city areas. King George Hospital in Goodmayes, Essex provides clinical services to a population of approximately 230 000; 17% are...

  • Shortening the treatment of tuberculosis. Mitchison, Denis A. // Nature Biotechnology;Feb2005, Vol. 23 Issue 2, p187 

    The article informs that a new diarylquinoline drug promises faster treatment for tuberculosis. Tuberculosis remains a major scourge throughout the world, killing 2-3 million people each year. Because existing antibiotic regimens against tuberculosis last six months, patient noncompliance often...

  • KNOWLEDGE ABOUT TUBERCULOSIS AND MULTI-DRUG RESISTANT TUBERCULOSIS AMONG INTERNS. Patle, Rupali A.; Khakse, Gautam M. // National Journal of Community Medicine;Jan-Mar2014, Vol. 5 Issue 1, p51 

    Background: Tuberculosis (TB) is an ancient disease with new threats of Multidrug resistant (MDR-TB) and Extensively drug resistant tuberculosis (XDR-TB). To treat and prevent this every health care personnel should have a thorough knowledge of it. Internship is a crucial period when knowledge...

  • Evaluation of underreporting tuberculosis in Central Italy by means of record linkage. Melosini, Lorenza; Vetrano, Umberto; Dente, Federico L.; Cristofano, Michele; Giraldi, Mauro; Gabbrielli, Luciano; Novelli, Federica; Aquilini, Ferruccio; Rindi, Laura; Menichetti, Francesco; Freer, Giulia; Paggiaro, Pierluigi L. // BMC Public Health;2012, Vol. 12 Issue 1, p472 

    Background: Tuberculosis (TB) surveillance systems have some pitfalls outside of a National Tuberculosis Program and lack of efficient surveillance hampers accurate epidemiological quantification of TB burden. In the present study we assessed the quality of surveillance at the University...

  • Resistance of multidrug-resistant strains ofMycobacterium tuberculosisfrom the Archangel oblast, Russia, to second-line anti-tuberculosis drugs. Toungoussova, O. S.; Mariandyshev, A. O.; Bjune, G.; Caugant, D. A.; Sandven, P. // European Journal of Clinical Microbiology & Infectious Diseases;Mar2005, Vol. 24 Issue 3, p202 

    Multidrug-resistant tuberculosis has become common all over the world, necessitating the inclusion of second-line drugs in treatment regimens. In the present study, the susceptibility of a selection of multidrug-resistant strains ofMycobacterium tuberculosisisolated in the Archangel oblast,...

  • Tuberculosis Resistance. Hampton, Tracy // JAMA: Journal of the American Medical Association;4/4/2007, Vol. 297 Issue 13, p1423 

    The article describes a research study that found that most cases of drug-resistant tuberculosis arose from new infections and not acquired resistance in the microorganism that causes the disease. These findings are in opposition to the common belief that resistance in treated patients is...

  • Multidrug-Resistant Tuberculosis (MDR-TB) in India: An Attempt to Link Biosocial Determinants. Atre, Sachin R.; Mistry, Nerges F. // Journal of Public Health Policy;2005, Vol. 26 Issue 1, p96 

    Multidrug-resistant tuberculosis (MDR-TB) has emerged as a possible threat to global tuberculosis control efforts in recent years. It is a challenge not only from a public health point of view but also in the context of global economy, especially in the absence of treatment for MDR-TB at...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics